Hyperuricemia is associated with hypertension, metabolic syndrome, preeclampsia, cardio-vascular disease and renal disease, all conditions associated with oxidative stress. We hypothesized that uric acid, a known antioxidant, might become prooxidative following its reaction with oxidants; and, thereby contribute to the pathogenesis of these diseases. Uric acid and 1,3-(15)N(2)-uric acid were reacted with peroxynitrite in different buffers and in the presence of alcohols, antioxidants and in human plasma. The reaction products were identified using liquid chromatography-mass spectrometry (LC-MS) analyses. The reactions generate reactive intermediates that yielded triuret as their final product. We also found that the antioxidant, ascorbate, could partially prevent this reaction. Whereas triuret was preferentially generated by the reactions in aqueous buffers, when uric acid or 1,3-(15)N(2)-uric acid was reacted with peroxynitrite in the presence of alcohols, it yielded alkylated alcohols as the final product. By extension, this reaction can alkylate other biomolecules containing OH groups and others containing labile hydrogens. Triuret was also found to be elevated in the urine of subjects with preeclampsia, a pregnancy-specific hypertensive syndrome that is associated with oxidative stress, whereas very little triuret is produced in normal healthy volunteers. We conclude that under conditions of oxidative stress, uric acid can form reactive intermediates, including potential alkylating species, by reacting with peroxynitrite. These reactive intermediates could possibly explain how uric acid contributes to the pathogenesis of diseases such as the metabolic syndrome and hypertension.
Hyperuricemia is associated with n class="Disease">hypertension, metabolic syndrome, preeclampsia, cardio-vascular disease and renal disease, all conditions associated with oxidative stress. We hypothesized that uric acid, a known antioxidant, might become prooxidative following its reaction with oxidants; and, thereby contribute to the pathogenesis of these diseases. Uric acid and 1,3-(15)N(2)-uric acid were reacted with peroxynitrite in different buffers and in the presence of alcohols, antioxidants and in human plasma. The reaction products were identified using liquid chromatography-mass spectrometry (LC-MS) analyses. The reactions generate reactive intermediates that yielded triuret as their final product. We also found that the antioxidant, ascorbate, could partially prevent this reaction. Whereas triuret was preferentially generated by the reactions in aqueous buffers, when uric acid or 1,3-(15)N(2)-uric acid was reacted with peroxynitrite in the presence of alcohols, it yielded alkylated alcohols as the final product. By extension, this reaction can alkylate other biomolecules containing OH groups and others containing labile hydrogens. Triuret was also found to be elevated in the urine of subjects with preeclampsia, a pregnancy-specific hypertensive syndrome that is associated with oxidative stress, whereas very little triuret is produced in normal healthy volunteers. We conclude that under conditions of oxidative stress, uric acid can form reactive intermediates, including potential alkylating species, by reacting with peroxynitrite. These reactive intermediates could possibly explain how uric acid contributes to the pathogenesis of diseases such as the metabolic syndrome and hypertension.
Authors: Silvia M Sanguinetti; Carlos Batthyány; Andrés Trostchansky; Horacio Botti; Graciela I López; Regina L W Wikinski; Homero Rubbo; Laura E Schreier Journal: Arch Biochem Biophys Date: 2004-03-15 Impact factor: 4.013
Authors: A Ahsan Ejaz; Bhagwan Dass; Vijaykumar Lingegowda; Michiko Shimada; Thomas M Beaver; Noel I Ejaz; Amer S Abouhamze; Richard J Johnson Journal: Int Urol Nephrol Date: 2012-05-31 Impact factor: 2.370
Authors: Rajesh Mohandas; Laura Sautina; Elaine Beem; Anna Schuler; Wai-Yan Chan; John Domsic; Robert McKenna; Richard J Johnson; Mark S Segal Journal: Exp Cell Res Date: 2014-06-09 Impact factor: 3.905
Authors: Marilda Mazzali; Mehmet Kanbay; Mark S Segal; Mohamed Shafiu; Diana Jalal; Daniel I Feig; Richard J Johnson Journal: Curr Rheumatol Rep Date: 2010-04 Impact factor: 4.592
Authors: Sergiu P Palii; Cesar S Contreras; Jeffrey D Steill; Stela S Palii; Jos Oomens; John R Eyler Journal: Arch Biochem Biophys Date: 2010-04-03 Impact factor: 4.013
Authors: Kyung Mee Kim; George N Henderson; Reginald F Frye; Cheryl D Galloway; Nancy J Brown; Mark S Segal; Witcha Imaram; Alexander Angerhofer; Richard J Johnson Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2008-11-25 Impact factor: 3.205